These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4131652)

  • 21. [Serum acid phosphatase levels following prostatic massage (author's transl)].
    Chiari R; Harzmann R; Züge E; Allner R
    Urol Int; 1976; 31(3):191-7. PubMed ID: 60817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasia.
    Rackley RR; Yang B; Pretlow TG; Abdul-Karim FW; Lewis TJ; McNamara N; Delmoro CM; Bradley EL; Kursh E; Resnick MI
    Cancer; 1991 Aug; 68(3):587-93. PubMed ID: 1712242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia.
    Vicentini C; Gravina GL; Angelucci A; Pascale E; D'Ambrosio E; Muzi P; Di Leonardo G; Fileni A; Tubaro A; Festuccia C; Bologna M
    J Cancer Res Clin Oncol; 2004 Apr; 130(4):217-21. PubMed ID: 14749923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
    Bauer HW; Schmeller NT
    Urology; 1984 Mar; 23(3):247-51. PubMed ID: 6199879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An assessment of serum acid and alkaline phosphatase determinations in prostatic cancer with a clinical validation of an acid phosphatase assay utilizing adenosine 3'-monophosphate as substrate.
    Goldberg DM; Ellis G
    J Clin Pathol; 1974 Feb; 27(2):140-7. PubMed ID: 4132966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Histochemical characterization of different tissue enzymes in prostate adenomas and carcinomas].
    Hajek J; Papousek F; Nemecek R; Hanselova M; Strmiska M
    Acta Urol Belg; 1985; 53(1):96-100. PubMed ID: 2581425
    [No Abstract]   [Full Text] [Related]  

  • 27. Leucine-arylamidase activity in untreated and treated benign prostatic hypertrophy and adenocarcinomatous prostate.
    Verlooy J; van Sande M; Van Camp K
    Acta Urol Belg; 1981 Oct; 49(4):491-5. PubMed ID: 6172970
    [No Abstract]   [Full Text] [Related]  

  • 28. Prostatic acid phosphatase and prostatic cancer.
    Foti AG; Cooper JF; Herschman H
    Recent Results Cancer Res; 1979; 67():45-9. PubMed ID: 88065
    [No Abstract]   [Full Text] [Related]  

  • 29. Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
    Debruyne FM; van Munster PJ; van Groeninghen JC; Kirkels WJ
    Urol Res; 1984; 12(5):233-7. PubMed ID: 6083652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of digital manipulation of the prostate on serum acid phosphatase levels in man.
    Pendse AK; Prakash RO; Babel AL
    Indian J Med Res; 1981 Sep; 74():479-81. PubMed ID: 6172376
    [No Abstract]   [Full Text] [Related]  

  • 31. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
    Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of activities of arginase, hexosaminidase, and leucine aminopeptidase in prostate fluid.
    Vafa AZ; Grover PK; Pretlow TG; Resnick MI
    Urology; 1993 Aug; 42(2):138-43. PubMed ID: 7690169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of prostate-specific antigen and prostatic acid phosphatase concentrations in serum before and 1-42 days after transurethral resection of the prostate and orchidectomy.
    Price A; Attwood SE; Grant JB; Gray TA; Moore KT
    Clin Chem; 1991 Jun; 37(6):859-63. PubMed ID: 1710953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of tumor markers in the diagnosis of prostatic cancer].
    Casas Terrón E; Mari Ruiz M; Molina Andreu E
    Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian and day-to-day variation of prostatic acid phosphatase.
    Nissenkorn I; Mickey DD; Miller DB; Soloway MS
    J Urol; 1982 Jun; 127(6):1122-4. PubMed ID: 6177878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [THE VALUE OF BIOLOGICAL EXAMINATIONS IN THE DIFFERENTIAL DIAGNOSIS OF PROSTATIC DISEASES].
    MICHON J
    Acta Urol Belg; 1964 Jan; 32():85. PubMed ID: 14111385
    [No Abstract]   [Full Text] [Related]  

  • 37. [THE VALUE OF BIOLOGICAL EXAMINATIONS IN THE DIFFERENTIAL DIAGNOSIS OF PROSTATIC DISEASES].
    BRENEZ J
    Acta Urol Belg; 1964 Jan; 32():100-3. PubMed ID: 14111370
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of prostatic massage on acid phosphatase in patients with and without benign prostatic hypertrophy.
    Glazener CM; Pringle R
    Br J Clin Pract; 1982 Sep; 36(9):305-6. PubMed ID: 6185127
    [No Abstract]   [Full Text] [Related]  

  • 39. Alterations in serum lactate dehydrogenase activity and its isoenzyme pattern after massage of the prostate. Value in differentiating carcinoma from benign hyperplasia of the prostate.
    Ishibe T
    Invest Urol; 1971 Sep; 9(2):104-8. PubMed ID: 5120368
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia.
    Kucur M; Isman FK; Balci C; Onal B; Hacibekiroglu M; Ozkan F; Ozkan A
    Urol Oncol; 2008; 26(1):47-52. PubMed ID: 18190830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.